Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SARS Immunity and Vaccination.

Minsheng Zhu1

  • 1Model Animal Research Institute of Nanjing University, China. zms@nicemice.cn

Cellular & Molecular Immunology
|October 13, 2005
PubMed
Summary

Severe acute respiratory syndrome (SARS) is a fatal disease caused by SARS coronavirus. Vaccination strategies targeting spike and nucleocapsid proteins show promise for preventing SARS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biosynthesis of polyamine-polyphosphate granules for colitis alleviation.

iScience·2026
Same author

An <i>Aeromonas</i> variant that produces aerolysin promotes susceptibility to ulcerative colitis.

Science (New York, N.Y.)·2025
Same author

CDCA5 knockdown potentiates olaparib sensitivity in BRCA1-mutated ovarian cancer through autophagy activation.

Discover oncology·2025
Same author

<i>Proteus mirabilis</i> exacerbates ulcerative colitis by inhibiting mucin production.

Frontiers in microbiology·2025
Same author

TMEM16A regulates satellite cell-mediated skeletal muscle regeneration by ensuring a moderate level of caspase 3 activity.

Stem cells (Dayton, Ohio)·2024
Same author

Clinicopathological analysis of bronchiolar adenoma combined with lung adenocarcinoma: Report of eight cases and literature review.

Histology and histopathology·2023

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Severe acute respiratory syndrome (SARS) is a critical infectious disease caused by the SARS coronavirus (SARS-CoV).
  • SARS-CoV infection significantly alters cytokine expression and reduces T lymphocyte populations (CD4+ and CD8+).
  • Humoral and cellular immune responses, including specific IgG and IgM antibodies, develop during SARS-CoV infection.

Purpose of the Study:

  • To investigate the immunological response to SARS-CoV infection.
  • To identify key viral components responsible for antibody production.
  • To evaluate potential vaccination strategies against SARS.

Main Methods:

  • Analysis of cytokine expression patterns during SARS-CoV infection.
  • Monitoring of T lymphocyte subset changes.
  • Detection and characterization of SARS-CoV-specific antibodies (IgG and IgM).
  • Identification of immunodominant viral proteins (spike and nucleocapsid).

Main Results:

  • SARS-CoV infection leads to dramatic cytokine stimulation and a decrease in CD4+ and CD8+ T cells.
  • SARS-specific IgG antibodies appear by the second week and are long-lasting, while IgM is transient.
  • The spike protein (especially the ACE-2 binding region) and nucleocapsid protein are major contributors to antibody production.
  • The nucleocapsid protein induces protective cytotoxic T lymphocytes (CTLs).

Conclusions:

  • The spike and nucleocapsid proteins are critical targets for SARS-CoV vaccine development.
  • Three prospective vaccination strategies include using spike subunits, nucleocapsid subunits, or inactivated SARS-CoV.
  • Understanding the immune response to SARS-CoV is crucial for designing effective vaccines.

Related Experiment Videos